Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    17635389 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Neuromuscular Blockade for Optimising Surgical Conditions During Spinal Surgery
Conditions: Neuromuscular Block;   Orthopedic Disorder of Spine;   Muscle Weakness
Interventions: Drug: Rocuronium 0.9 mg/kg;   Drug: Rocuronium 0.6 mg/kg
2 Not yet recruiting The Onset Time of Rocuronium in Emergency and Elective Surgery
Conditions: Inguinal Hernia;   Acute Appendicitis
Interventions: Drug: Rocuronium elective surgery;   Drug: Rocuronium emergency surgery;   Drug: Propofol;   Drug: Fentanyl;   Other: Ringer Lactate;   Device: Acceleromyography device
3 Completed Shortening of the Twitch Stabilization Period by Tetanic Stimulation in Acceleromyography in Children and Young Adults
Condition: Train-of-Four-Monitoring
Interventions: Other: Tetanic stimulation;   Other: Staircase Stimulation
4 Completed Pharmacokinetic and Pharmacodynamic of Rocuronium
Condition: Neuromuscular Blockade
Intervention: Drug: Rocuronium Bromide
5 Completed Remifentanil Versus Sufentanil for Intubation Condition Without Myorelaxant
Condition: Anaesthetic Induction
Interventions: Drug: Remifentanyl - sufentanil placebo;   Drug: Sufentanil - remifentanyl placebo
6 Completed Residual Curarization and Its Incidence at Tracheal Extubation in China
Condition: Residual Curarization
Intervention: Device: TOF-Watch SX® Monitoring of NMB
7 Completed Magnesium Sulphate and Rocuronium in Patients Over 60
Condition: Head and Neck Cancer
Intervention: Drug: Magnesium Sulfate

Indicates status has not been verified in more than two years